投稿信息
投稿信息
审稿周期
投稿命中率
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2018年中国人文章占该期刊总数量暂无数据 (2017年为54.98%)
自引率
12.0 %
年文章数
633
NCBI查询
偏重的研究方向
期刊简介
稿件收录要求
稿件收录要求
Tumor Biology is a peer reviewed, open access journal publishing experimental and clinical cancer research. Tumor Biology places special emphasis on articles covering all aspects of tumor markers and tumor targeting, but studies in other areas of clinical and translational cancer research are considered in order to promote connections and discoveries across different studies or disciplines.
The journal publishes original articles, reviews and commentaries. All submissions are subject to rigorous peer review and are selected on the basis of whether the research is sound and deserves publication.
Why publish in Tumor Biology?
Tumor Biology is the Official Journal of the International Society of Oncology and BioMarkers (ISOBM).
The journal publishes original articles, reviews and commentaries. All submissions are subject to rigorous peer review and are selected on the basis of whether the research is sound and deserves publication.
Why publish in Tumor Biology?
- Tumor Biology is indexed by MEDLINE and Thomson Reuters.
- Rapid but rigorous peer review, and quick decision times
- Open access dissemination of your article after payment of an article processing charge (APC) of 1,500 USD*
- Authors retain copyright under a Creative Commons license.
Tumor Biology is the Official Journal of the International Society of Oncology and BioMarkers (ISOBM).
